These include direct inhibition of inflammasome components, caspase-1 blockade, modulation of immune responses using anti-inflammatory agents, and targeted manipulation of gut microbiota and bile acid metabolism, which are increasingly recognized for their roles in liver homeostasis and injury response
Switching from semaglutide to tirzepatide often restarts the weight loss trajectory, presumably by engaging additional receptor pathways that monotherapy does not activate
If your medication regimen has changed since your preoperative evaluation, inform your anesthesiologist immediatelythis allows them to implement appropriate safety measures based on current information
However, NHS access is governed by the narrower criteria set out in NICE Technology Appraisal TA875, which restricts use to people meeting defined eligibility thresholds within specialist weight management services, and for a time-limited period (currently up to two years in the NHS pathway)